10X GENOMICS INC-CLASS A (TXG) Stock Balance Sheet
NASDAQ:TXG - Nasdaq - US88025U1097 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 398.16M | 359.28M | 219.70M | 587.40M | 663.60M | |||
| Marketable Securities | 0.00 | 29.41M | 210.20M | N/A | N/A | |||
| Receivables | 83.53M | 114.83M | 104.20M | 85.30M | 51.20M | |||
| Inventories | 94.05M | 73.71M | 81.60M | 60.00M | 30.00M | |||
| Other Current Assets | 18.16M | 18.79M | 19.20M | 14.90M | 29.60M | |||
| Total Current Assets | 593.89M | 596.02M | 635.00M | 747.60M | 774.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 318.34M | 344.93M | 359.20M | 230.40M | 119.80M | |||
| Goodwill | 4.51M | 4.51M | 4.50M | 4.50M | N/A | |||
| Intangibles | 16.15M | 16.62M | 22.90M | 25.40M | 22.40M | |||
| Other Non-Current Assets | 4.90M | 3.06M | 7.40M | 10.90M | 12.80M | |||
| Total Non-Current Assets | 343.90M | 369.12M | 394.00M | 271.20M | 154.90M | |||
| TOTAL ASSETS | 937.79M | 965.14M | 1.03B | 1.02B | 929.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 58.81M | 80.70M | 87.70M | 75.80M | 92.30M | |||
| Accounts Payable | 26.21M | 15.74M | 21.60M | 17.40M | 4.70M | |||
| Other Current Liabilities | 36.22M | 30.73M | 21.70M | 17.20M | 21.10M | |||
| Total Current Liabilities | 121.23M | 127.16M | 131.00M | 110.40M | 118.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 93.75M | 96.94M | 92.30M | 90.90M | 72.10M | |||
| Total Non-Current Liabilities | 93.75M | 96.94M | 92.20M | 90.90M | 72.20M | |||
| TOTAL LIABILITIES | 214.99M | 224.10M | 223.20M | 201.30M | 190.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.42B | -1.28B | -1.03B | -863.30M | -805.10M | |||
| Additional Paid In Capital | 2.14B | 2.03B | 1.84B | 1.68B | 1.54B | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 32.00K | -429.00K | -4.30M | 0.00 | -100.00K | |||
| Shares Outstanding | 121.04M | 119.10M | 115.20M | 112.50M | 108.50M | |||
| Tangible Book Value per Share | 5.80 | 6.04 | 6.76 | 7.00 | 6.61 | |||
| Total Shareholders' Equity | 722.80M | 741.04M | 805.70M | 817.60M | 739.10M | |||
| TOTAL LIABILITIES AND EQUITY | 937.79M | 965.14M | 1.03B | 1.02B | 929.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.90 | 4.69 | 4.85 | 6.77 | 6.56 | |||
| Return On Assets (ROA) | -19.47% | -26.43% | -16.13% | -5.71% | -58.40% | |||
| Return On Equity (ROE) | -25.26% | -34.42% | -20.60% | -7.12% | -73.43% | |||
All data in USD , ROIC based on taxRate of 0.21